Ryan Palmer couldn't wait for 2018 to arrive after year when wife faced breast cancer and he had shoulder surgery
MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive.
A new study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens.
U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza … Click to Continue »
The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer...
The drug, part of a class called PARP inhibitors, was already approved for advanced ovarian cancer.
(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene.
A chemical found in bread and a range of other common foods can thwart treatment for breast cancer, scientists have warned. New research suggested the benefits of the “breakthrough” new drug palbociclib, which is given to women with oestrogen receptor-positive breast cancer, was effectively reversed by xenoestrogens. Show More Summary
Julia Louis-Dreyfus' last day of chemo was Thursday and her 2 sons celebrated the milestone in her breast cancer battle with a video tribute... and an assist from Michael Jackson. Julia posted the vid of 20-year-old Charlie and 25-year-old Henry…
Julia Louis-Dreyfus has the fighting spirit, thanks to her amazing kids! The Veep actress, who revealed that she was diagnosed with breast cancer back in September of 2017, posted an encouraging – and hilarious! – update on Thursday (January 11). PHOTOS: Check out the latest pics of Julia Louis-Dreyfus Julia‘s boys, Charlie Hall, 20, and [...]
There is a surprising new trend among the female millennial population. Contrary to the steadfast beliefs of their mothers and grandmothers, many millennial women are saying, “Enough is enough!” Depending upon whom you ask, millennials are identified as those born between 1981 and 1996. Good or bad (again depending upon whom you ask) millennials are […]
(Scripps Research Institute) Scientists from The Scripps Research Institute have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for treating breast cancer.
Two months ago, I joined a club nobody wants to be a member of – the 1 in 8 women who develop breast cancer at some point in their lifetimes. It turned up on a
(Reuters Health) - - Women with breast cancer often feel rushed to make a decision about surgery, and some of them might benefit from more time and better educational materials to inform their treatment choices, two recent studies suggest.
In 2012, Patti and Lynn set out to section hike the Pacific Crest Trail. Soon afterwards, life changed for the couple when Patti was diagnosed with breast cancer. Determined not to let cancer live her life, Patti continued to section...Show More Summary
University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer. "RYBP...Show More Summary
(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.
(University of Alberta Faculty of Medicine & Dentistry) University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer.